Cargando…

Assessment of Newly Proposed Clinical Criteria to Identify HNF1A MODY in Patients with an Initial Diagnosis of Type 1 or Type 2 Diabetes Mellitus

The most common form of maturity-onset diabetes of the young (MODY) is caused by mutations in the hepatocyte nuclear factor 1A (HNF1A) gene. However, most HNF1A mutation-carriers are initially misdiagnosed with type 1 (T1DM) or type 2 (T2DM) diabetes mellitus; hence, they often receive nonoptimal tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grzanka, Malgorzata, Matejko, Bartlomiej, Szopa, Magdalena, Kiec-Wilk, Beata, Malecki, Maciej T., Klupa, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749764/ https://www.ncbi.nlm.nih.gov/pubmed/26942212 http://dx.doi.org/10.1155/2016/4243784

Ejemplares similares

Comparison of Glomerular Filtration Rate Estimation from Serum Creatinine and Cystatin C in HNF1A-MODY and Other Types of Diabetes
por: Szopa, Magdalena, et al.
Publicado: (2015)

Are late-night eating habits and sleep duration associated with glycemic control in adult type 1 diabetes patients treated with insulin pumps?
por: Matejko, Bartlomiej, et al.
Publicado: (2015)

Circulating ghrelin level is higher in HNF1A–MODY and GCK–MODY than in polygenic forms of diabetes mellitus
por: Nowak, Natalia, et al.
Publicado: (2015)

Qualitative Parameters of the Colonic Flora in Patients with HNF1A-MODY Are Different from Those Observed in Type 2 Diabetes Mellitus
por: Mrozinska, Sandra, et al.
Publicado: (2016)

Basal Insulin Dose in Adults with Type 1 Diabetes Mellitus on Insulin Pumps in Real-Life Clinical Practice: A Single-Center Experience
por: Matejko, Bartłomiej, et al.
Publicado: (2018)

Predictors of the maximal oxygen consumption in adult patients with type 1 diabetes treated with personal insulin pumps
por: Matejko, Bartłomiej, et al.
Publicado: (2021)

A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus
por: Hohendorff, J., et al.
Publicado: (2017)

Cystatin C is not a good candidate biomarker for HNF1A-MODY
por: Nowak, Natalia, et al.
Publicado: (2012)

Quality of life in the course of a one-year use of an advanced hybrid closed-loop system in adults with type 1 diabetes previously naïve to advanced diabetes technology
por: Cyranka, Katarzyna, et al.
Publicado: (2023)

A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations
por: Szopa, Magdalena, et al.
Publicado: (2019)

The Gut Microbiota Profile According to Glycemic Control in Type 1 Diabetes Patients Treated with Personal Insulin Pumps
por: Mrozinska, Sandra, et al.
Publicado: (2021)

Variants influencing age at diagnosis of HNF1A-MODY
por: Ludwig-Słomczyńska, Agnieszka H., et al.
Publicado: (2022)

The Impact of a Pure Protein Load on the Glucose Levels in Type 1 Diabetes Patients Treated with Insulin Pumps
por: Klupa, Tomasz, et al.
Publicado: (2015)

Transitioning of People With Type 1 Diabetes From Multiple Daily Injections and Self-Monitoring of Blood Glucose Directly to MiniMed 780G Advanced Hybrid Closed-Loop System: A Two-Center, Randomized, Controlled Study
por: Matejko, Bartłomiej, et al.
Publicado: (2022)

Improvement of Selected Psychological Parameters and Quality of Life of Patients With Type 1 Diabetes Mellitus Undergoing Transition From Multiple Daily Injections and Self-Monitoring of Blood Glucose Directly to the MiniMed 780G Advanced Hybrid Closed-Loop System: Post hoc Analysis of a Randomized Control Study
por: Cyranka, Katarzyna, et al.
Publicado: (2023)

Insulin pump settings and glucose patterns during a 1008-km non-stop bicycle race in a patient with type 1 diabetes mellitus
por: Klupa, Tomasz, et al.
Publicado: (2018)

Depression and quality of sleep in patients with type 1 diabetes being under regular diabetes care
por: Cyranka, K., et al.
Publicado: (2023)

Insulin-induced Lipohypertrophy in Patients with Type 1 Diabetes Mellitus Treated with an Insulin Pump
por: Ucieklak, Damian, et al.
Publicado: (2022)

Assessment of selected muscle damage markers and zonulin concentration after maximum-intensity exercise in men with type 1 diabetes treated with a personal insulin pump
por: Matejko, Bartłomiej, et al.
Publicado: (2023)

Psychological Crisis Intervention for COVID-19 Lockdown Stress in Patients With Type 1 Diabetes Mellitus: Survey Study and Qualitative Analysis
por: Cyranka, Katarzyna, et al.
Publicado: (2021)

Physiological Characteristics of Type 1 Diabetes Patients during High Mountain Trekking
por: Matejko, Bartłomiej, et al.
Publicado: (2020)

Metabolic control in type 1 diabetes patients practicing combat sports: at least two-year follow-up study
por: Benbenek-Klupa, Teresa, et al.
Publicado: (2015)

Changes in Oxidative and Nitrosative Stress Indicators and Vascular Endothelial Growth Factor After Maximum-Intensity Exercise Assessing Aerobic Capacity in Males With Type 1 Diabetes Mellitus
por: Tota, Łukasz, et al.
Publicado: (2021)

Two Cases of Diabetic Ketoacidosis in HNF1A-MODY Linked to Severe Dehydration: Is it time to change the diagnostic criteria for MODY?
por: Pruhova, Stepanka, et al.
Publicado: (2013)

Higher scanning frequency is correlated with less fear of hypoglycemia in type 1 diabetes patients using isCGM
por: Hohendorff, Jerzy, et al.
Publicado: (2022)

Evaluation of Psychological Resources of Young Adults With Type 1 Diabetes Mellitus During the Transition From Pediatric to Adult Diabetes Clinics: Multicenter Cross-sectional Study
por: Cyranka, Katarzyna, et al.
Publicado: (2023)

Type 1 diabetes outpatient care and treatment effectiveness during COVID-19: A single-center cohort study
por: Kania, Michał, et al.
Publicado: (2023)

HNF1B-MODY Masquerading as Type 1 Diabetes: A Pitfall in the Etiological Diagnosis of Diabetes
por: Francis, Youmna, et al.
Publicado: (2022)

Low prevalence of diabetic retinopathy in patients with long-term type 1 diabetes and current good glycemic control - one-center retrospective assessment
por: Surowiec, Paulina, et al.
Publicado: (2021)

Double Heterozygous Mutations Involving Both HNF1A/MODY3 and HNF4A/MODY1 Genes: A case report
por: Forlani, Gabriele, et al.
Publicado: (2010)

Differential regulation of serum microRNA expression by HNF1β and HNF1α transcription factors
por: Fendler, Wojciech, et al.
Publicado: (2016)

Insights from basic adjunctive examinations of GCK‐MODY, HNF1A‐MODY, and type 2 diabetes: A systemic review and meta‐analysis
por: Liu, Jing, et al.
Publicado: (2023)

Circulating CD36 Is Reduced in HNF1A-MODY Carriers
por: Bacon, Siobhan, et al.
Publicado: (2013)

Identification of a novel hepatocyte nuclear factor-1 alpha (HNF1A) variant in maturity onset diabetes of the young type 3 (HNF1A-MODY)
por: Verma, Megha, et al.
Publicado: (2022)

Using Clinical Indices to Distinguish MODY2 (GCK Mutation) and MODY3 (HNF1A Mutation) from Type 1 Diabetes in a Young Chinese Population
por: Fu, Junling, et al.
Publicado: (2019)

Granuloma annulare and necrobiosis lipoidica in a patient with HNF1A-MODY
por: Brandes, Gabriela Irene Garcia, et al.
Publicado: (2022)

Genetic and Clinical Characterization of Patients with HNF1B-Related MODY in Croatia
por: Baretić, Maja, et al.
Publicado: (2023)

A Case of Novel Mutation of HNF1B in Maturity-onset Diabetes of the Young Type 5 (MODY5)
por: Jo, Wakako, et al.
Publicado: (2012)

Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level
por: Fendler, Wojciech, et al.
Publicado: (2014)

A cross‐sectional study of patients referred for HNF1B‐MODY genetic testing due to cystic kidneys and diabetes
por: Sztromwasser, Paweł, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nch4asiijir8ckpnv4ja9vvu4o